Oncology Central

Emerging immunotherapy in pediatric lymphoma


Hodgkin and non-Hodgkin lymphoma collectively are the third most common cancer diagnosed in children each year. For children who relapse or have refractory disease, outcomes remain poor. Immunotherapy has recently emerged as a novel approach to treat hematologic malignancies.

To view restricted content, please:

Leave A Comment